​

Citius Pharmaceuticals Ownership | Who Owns Citius Pharmaceuticals?

OverviewForecastRevenueFinancialsChart

Citius Pharmaceuticals Ownership Summary

Citius Pharmaceuticals is owned by 0.04% institutional investors, 5.74% insiders, and 94.22% retail investors. Blackrock is the largest institutional shareholder, holding 1.14% of CTXR shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.60% of its assets in Citius Pharmaceuticals shares.

CTXR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCitius Pharmaceuticals0.04%5.74%94.22%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock1.81M1.14%$1.05M
Northern trust1.06M0.66%$615.83K
Bank of america corp /de/159.42K0.10%$92.94K
Barclays37.82K0.02%$22.00K
Rhumbline advisers30.04K0.02%$17.54K
Citadel advisors24.70K0.02%$14.42K
Morgan stanley9.74K0.01%$5.69K
Macquarie group6.89K0.00%$4.02K
Russell investments group5.46K0.00%$3.19K
Wells fargo & company/mn4.00K0.00%$2.33K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Northern trust1.06M0.00%$615.83K
Geode capital management---
Blackrock1.81M-$1.05M
Proshare advisors---
Wr wealth planners---
Legal & general group---
Voya investment management---
New york state common retirement fund---
Nelson, van denburg & campbell wealth management group---
Price t rowe associates inc /md/---

Top Buyers

HolderShares% AssetsChange
Bank of america corp /de/159.42K-107.23K
Citadel advisors24.70K-24.70K
Macquarie group6.89K-6.89K
Russell investments group5.46K-5.46K
Eversource wealth advisors---16.00

Top Sellers

HolderShares% AssetsChange
Armistice capital---7.28M
Blackrock1.81M--6.92M
Vanguard group---6.44M
Geode capital management---1.88M
Blackrock funding, inc. /de---1.81M

New Positions

HolderShares% AssetsChangeValue
Macquarie group6.89K-6.89K$4.02K
Russell investments group5.46K-5.46K$3.19K

Sold Out

HolderChange
Eversource wealth advisors-16.00
Nelson, van denburg & campbell wealth management group-18.00
Farther finance advisors-80.00
Wr wealth planners-100.00
Pnc financial services group-177.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20243-94.92%76,616-99.68%-0.02%--100.00%1-96.00%
Sep 30, 202455-21.43%23,175,356-23.61%133.66%12-62.50%2538.89%
Jun 30, 202470-2.78%30,339,56412.37%196.61%3214.29%18-21.74%
Mar 31, 202472-4.00%26,999,7700.67%165.97%28-24.32%2391.67%
Dec 31, 202375-1.32%26,820,0007.67%166.43%3732.14%12-36.84%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF4.14M2.60%-1.00
Vanguard Total Stock Mkt Idx Inv165.58K1.89%-
Vanguard Institutional Extnd Mkt Idx Tr78.31K0.89%-
Fidelity Extended Market Index46.77K0.48%10.12K
NT R2000 Index Fund - NL316.31K0.17%-58.09K
NT R2000 Value Index Fund - NL279.80K0.15%-55.32K
NT R2000 Index Fund - DC - NL - 2250.30K0.14%-47.02K
Northern Trust Russell 2000 Value Index249.69K0.14%6.16K
NT R2000 Value Index Fund - L249.69K0.14%6.16K
BlackRock Extended Equity Market K230.77K0.13%-98.00

Recent Insider Transactions

DateNameRoleActivityValue
Sep 27, 2019Mazur Leonard L Executive ChairmanBuy$1.72M
Sep 27, 2019Mazur Leonard L Executive ChairmanBuy$2.00M
Sep 27, 2019HOLUBIAK MYRON Z President and CEOBuy$500.00K
Sep 27, 2019HOLUBIAK MYRON Z President and CEOBuy$430.12K
Apr 03, 2019Mazur Leonard L Executive ChairmanBuy$1.80M

Insider Transactions Trends

DateBuySell
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q1--

CTXR Ownership FAQ

Who Owns Citius Pharmaceuticals?

Citius Pharmaceuticals shareholders are primarily institutional investors at 0.04%, followed by 5.74% insiders and 94.22% retail investors. The average institutional ownership in Citius Pharmaceuticals's industry, Biotech Stocks , is 63.96%, which Citius Pharmaceuticals falls below.

Who owns the most shares of Citius Pharmaceuticals?

Citius Pharmaceuticals’s largest shareholders are Blackrock (1.81M shares, 1.14%), Northern trust (1.06M shares, 0.66%), and Bank of america corp /de/ (159.42K shares, 0.10%). Together, they hold 1.90% of Citius Pharmaceuticals’s total shares outstanding.

Does Blackrock own Citius Pharmaceuticals?

Yes, BlackRock owns 1.14% of Citius Pharmaceuticals, totaling 1.81M shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.05M$. In the last quarter, BlackRock decreased its holdings by -6.921M shares, a -79.31% change.

Who is Citius Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Northern trust is Citius Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 1.06M Citius Pharmaceuticals shares, valued at 615.83K$.

Who is the top mutual fund holder of Citius Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Citius Pharmaceuticals shares, with 2.60% of its total shares outstanding invested in 4.14M Citius Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools